The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
Official Title: A Pilot Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
Study ID: NCT01679470
Brief Summary: This is an open-label, single-center, single-dose efficacy pilot study of AuroLase Therapy in the treatment of subjects with primary and/or metastatic tumors of the lung where there is airway obstruction. In this study patients will be given a systemic IV infusion of particles and a subsequent escalating dose of laser radiation delivered by optical fiber via bronchoscopy.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Cancer Treatment Centers of America Eastern Regional Medical Center, Philadelphia, Pennsylvania, United States
Name: Glenn Goodrich, PhD
Affiliation: Nanospectra Biosciences
Role: STUDY_DIRECTOR